SYN-005
| Source | Web search |
|---|---|
| Organization | Synthetic Biologics + Intrexon |
| Market status | Under Development |
| Industry | Health |
| Value chain stage | Finished Product |
| Intended consumer | Commercial |
| Production process | Closed Production |
| Business models | B2B |
| Product categories | Medical Treatment |
| Biotech components | Molecule |
| Organization type(s) | Public Company |
| Funding types | Shareholder Investment |
| Known funding amount | $24,800,000 USD |
| Country of production | USA |
| Country of distribution | USA |
| Trading symbol | SYN |
| Trading exchange | NYSEMKT |